Cite
HARVARD Citation
Ono, R. et al. (2023). A phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of danuglipron (PF‐06882961), an oral small‐molecule glucagon‐like peptide‐1 receptor agonist, in Japanese adults with type 2 diabetes mellitus. Diabetes, obesity & metabolism. 25 (3), pp. 805-814. [Online].